These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7236001)

  • 1. Draft guidelines on mutagenicity testing of new drugs issued by the CPMP. A four test screen.
    Draper MH; Griffin JP
    Arch Toxicol; 1980 Nov; 46(1-2):9-19. PubMed ID: 7236001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity testing of pharmaceuticals: present status. Introduction.
    Zbinden G
    Arch Toxicol; 1980 Nov; 46(1-2):1-7. PubMed ID: 7235987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-clinical local tolerance testing of medicinal products. CPMP Working Party on Safety of Medicinal Products.
    Pharmacol Toxicol; 1991 Mar; 68(3):233-6. PubMed ID: 2057456
    [No Abstract]   [Full Text] [Related]  

  • 6. Report from the working group on the in vivo mammalian bone marrow chromosomal aberration test.
    Tice RR; Hayashi M; MacGregor JT; Anderson D; Blakey DH; Holden HE; Kirsch-Volders M; Oleson FB; Pacchierotti F; Preston RJ
    Mutat Res; 1994 Jun; 312(3):305-12. PubMed ID: 7514742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese guidelines for mutagenicity testing. Ministry of Agriculture, Forestry and Fisheries; Ministry of Health and Welfare; Ministry of Labor.
    Sofuni T
    Environ Mol Mutagen; 1993; 21(1):2-7; discussion 46-57. PubMed ID: 8419152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with mutagenicity testing of new drugs: viewpoint of a regulatory agency.
    Madle S; Korte A; Bass R
    Mutat Res; 1987 Aug; 182(4):187-92. PubMed ID: 3302693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
    Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
    Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact.
    Müller L; Kikuchi Y; Probst G; Schechtman L; Shimada H; Sofuni T; Tweats D
    Mutat Res; 1999 May; 436(3):195-225. PubMed ID: 10354523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity Assessment of Nanomaterials: Recommendations on Best Practices, Assays, and Methods.
    Elespuru R; Pfuhler S; Aardema MJ; Chen T; Doak SH; Doherty A; Farabaugh CS; Kenny J; Manjanatha M; Mahadevan B; Moore MM; Ouédraogo G; Stankowski LF; Tanir JY
    Toxicol Sci; 2018 Aug; 164(2):391-416. PubMed ID: 29701824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic toxicity assessment: employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing.
    Pfuhler S; Albertini S; Fautz R; Herbold B; Madle S; Utesch D; Poth A;
    Toxicol Sci; 2007 Jun; 97(2):237-40. PubMed ID: 17303579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-mammal mutagenicity tests: evaluation of five methods.
    Russell LB; Matter BE
    Mutat Res; 1980 May; 75(3):279-302. PubMed ID: 6991917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian cell HPRT gene mutation assay: test methods.
    Johnson GE
    Methods Mol Biol; 2012; 817():55-67. PubMed ID: 22147568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The way forward in reproductive/developmental toxicity testing.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical aspects of mutagenicity testing strategy: an industrial perspective.
    Gollapudi BB; Krishna G
    Mutat Res; 2000 Nov; 455(1-2):21-8. PubMed ID: 11113465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to assess the mutagenic potential of cosmetic products without animal tests?
    Speit G
    Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens.
    Jacobson-Kram D; Contrera JF
    Toxicol Sci; 2007 Mar; 96(1):16-20. PubMed ID: 17194803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive.
    Tweats DJ; Scott AD; Westmoreland C; Carmichael PL
    Mutagenesis; 2007 Jan; 22(1):5-13. PubMed ID: 17142828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity test systems for the detection of chromosome aberrations in vivo.
    Matter BE; Tsuchimoto T
    Arch Toxicol; 1980 Nov; 46(1-2):89-98. PubMed ID: 7236000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.